stop_circleTerminated/Withdrawn

Sunscreening Agents

Bayer Identifier:

19605

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Determination of the sun protection factor (SPF) of a sunscreen lotion

Trial purpose

The purpose of this study is to determine the effectiveness of the sun protection products to be tested.The testing involves applying various sunscreen products to small areas of skin and then simulating the effects of the sun using an artificial sunlight source.

Key Participants Requirements

Sex

All

Age

18 - 70 Years
  • - Individuals over the age of consent (age range 18 to 70 years).
    - Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator.
    - Individuals who have completed a preliminary medical history evaluation.
    - Individuals who have read, understood and signed an informed consent document relating to the specific study to which they are subscribing.
    - Individuals with no known abnorma l response to sunlight.
  • - Individuals taking medication which in the opinion of the investigator would mask or interfere with the results.
    - Individuals with chronic skin allergies.
    - Individuals with suntan or sunburn.
    - Individuals with abnormal reaction to the sun.
    - Pregnant or lactating females.
    - Subjects accustomed to using sun beds.
    - Subjects who have participated in an SPF study within the last two months.

Trial summary

Enrollment Goal
3
Trial Dates
December 2018 - December 2018
Phase
N/A
Could I Receive a placebo
No
Products
BAY987517
Accepts Healthy Volunteer
Yes

Where to participate

StatusInstitutionLocation
Completed
EUROFINS Dermatest Pty LtdRockdale, 2216, Australia

Primary Outcome

  • Mean sun protection factor
    date_rangeTime Frame:
    Up to 24 hours

Trial design

Determination of the sun protection factor (SPF) of a cosmetic sunscreen lotion according to the ISO 24444 standard
Trial Type
Interventional
Intervention Type
Drug
Trial Purpose
Prevention
Allocation
N/A
Blinding
N/A
Assignment
Single Group Assignment
Trial Arms
1